Allen T M. Long- circulating (sterically stabilized) liposom es for targeted drug delivery[J]. Trends Pharmacol Sci, 1994, 15 (7): 215.
[4]
Nagayasu A, Shimooka Y, Kinouchi T, et al. Effects of fluidity and vesicle size on antitumor activity and immunosuppressive activity of liposomes loaded with daunorubicin[J] . Biol Pharm Bull, 1994, 17 (7): 935.
[5]
Nagayasu A, Uehiyama K, Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal an titum or drugs[J]. Adv Drug Deliv Rev, 1999, 40(1): 75.
[6]
He Z Y, Zheng X, Wu X H, et al. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery[J]. Int J Pharm, 2010, 397:147.
Tian Q, Wang W, He X T, et al. Glycyrrhetinic acid-modified nanoparticles for drug delivery: preparation and characterization[J]. Chin Sci Bull, 2009, 54(18): 3927.
Ishida T, Ichihara M, Wang X, et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes[J]. J Controlled Release, 2006, 112: 15.
Dong Y, Feng S S. Methoxy poly (ethylene glycol) -poly (lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs [J]. Biomaterials, 2004, 25: 2843.
[17]
Zhang Z,Feng S S. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release[J]. Biomaterials,2006,27(2):262.
[18]
Yu Fan, He Chenghua, Ayman Y Waddad, et al. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion[J]. Drug Dev Ind Pharm, 2013, doi: 10.3109/03639045.
[19]
Nicholas A R, Scott M J, Kennedy N I, et al. Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles[J]. Biochim Biophys Acta,2000,1463:167.
[20]
Li Jing, Huo Meirong, Wang Jing, et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic aciddeoxycholic acid conjugates for targeted intracellular delivery of paclitaxel[J]. Biomaterials, 2011, 33: 2310.
Moghimi S M, Davis S S. Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection[J]. Crit Rev Ther Drug Carrier Syst, 1994, 11: 31.
